CCDC30 and hepatocellular carcinoma: Compared with the control group, PFDN6L overexpression reduced both mRNA and protein levels of phosphorylated AKT and ERK1/2, suggesting that it suppresses HCC cell proliferation by inhibiting the AKT and ERK1/2 signaling pathways (Fig. 5A,B).